Resource pages answer a practical question: where does a laboratory obtain a model, a sample, a reference material or a method, and what does the supplier or custodian say about access. Each child page records the scope of what was checked, the date, and any limit on the source, such as a page that could be read only in part. Read access terms and availability at the custodian before planning work, because they change.
The section sits beside research overview, prevention research and the therapeutics overview. The child pages are listed automatically below this introduction. They include models, strains and isolates, biobanks, reference materials, datasets, registries and cohorts, assays and protocols and antibodies and reagents.
Explore
- Antibodies and reagentsThe POM monoclonal antibody panel to prion protein: epitopes, species reactivity and stated limits. Supplier and availability details are not covered.
- Assays and protocolsPublished performance of seed amplification assays for prion disease in CSF and blood: a Canadian prospective series, a 2026 modified assay and a sheep blood comparison.
- DatasetsPublic and summary-level datasets relevant to prion disease research: population exome data, published supplementary tables, surveillance statistics and trial data-sharing statements.
- Registries and cohortsNational prion disease surveillance registries and a registered pre-symptomatic cohort trial: what each records, cohort sizes and the limits of comparing them.
- Strains and isolatesHow published studies classify scrapie and chronic wasting disease strains: four classical scrapie strain groups and different spillover indices for Norwegian and North American CWD.